Update in Interstitial Lung Disease 2014

Am J Respir Crit Care Med. 2015 Sep 1;192(5):538-43. doi: 10.1164/rccm.201504-0768up.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Doxycycline / therapeutic use
  • Enzyme Inhibitors / therapeutic use*
  • Humans
  • Idiopathic Pulmonary Fibrosis / diagnosis
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Idiopathic Pulmonary Fibrosis / metabolism
  • Immunosuppressive Agents / therapeutic use
  • Indoles / therapeutic use*
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / drug therapy
  • Lung Diseases, Interstitial / metabolism
  • Lymphangioleiomyomatosis / diagnosis
  • Lymphangioleiomyomatosis / drug therapy
  • Lymphangioleiomyomatosis / metabolism
  • Pyridones / therapeutic use*
  • Sarcoidosis, Pulmonary / diagnosis
  • Sarcoidosis, Pulmonary / drug therapy
  • Sarcoidosis, Pulmonary / metabolism
  • Sirolimus / therapeutic use
  • Smoking
  • Tomography, X-Ray Computed
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Enzyme Inhibitors
  • Immunosuppressive Agents
  • Indoles
  • Pyridones
  • Tumor Necrosis Factor-alpha
  • pirfenidone
  • nintedanib
  • Doxycycline
  • Sirolimus